Update Q3 2022
We want to thank you for your continued interest and excitement to be part of the Dawah Pharma family. Recently, the Dawah...
Update Q3 2022
Dawah Pharmaceuticals is Gearing Up to Enter the US Market
Dawah Pharmaceuticals Updates | December 2019
Our First Drug to Market 2Q2020
Dawah Quarterly Newsletter and Industry News
Investor Update: FDA Submission Correspondence
Dawah Pharmaceuticals is No Longer a Startup
Sanofi Agrees To Sell European Generics Unit To Advent For $2.2B
Fresenius' $4.3B Buyout of Akorn Threatened by Data Integrity Probe
2017 Was Another Record-Setting Year for Generic Drugs
Novartis readies to auction U.S. generic pills business: sources
What is a Sterile Injectable?